SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2009.
  • 2
    Reid ME, Marshall JR, Roe D, et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1006-1011.
  • 3
    Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol. 2009; 170: 863-872.
  • 4
    Luchtenborg M, White KK, Wilkens L, Kolonel LN, Le Marchand L. Smoking and colorectal cancer: different effects by type of cigarettes? Cancer Epidemiol Biomarkers Prev. 2007; 16: 1341-1347.
  • 5
    Anderson JC, Attam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol. 2003; 98: 2777-2783.
    Direct Link:
  • 6
    Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the Cancer Prevention Study II. J Natl Cancer Inst. 2000; 92: 1888-1896.
  • 7
    Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004; 126: 1733-1741.
  • 8
    Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults—United States, 2006. MMWR Morb Mortal Wkly Rep. 2007; 56: 1157-1161.
  • 9
    Park ER, Japuntich S, Temel J, et al. A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol. 2011; 6: 1059-1065.
  • 10
    Emmons KM, McBride CM, Puleo E, et al. Prevalence and predictors of multiple behavioral risk factors for colon cancer. Prev Med. 2005; 40: 527-534.
  • 11
    Munro AJ, Bentley AH, Ackland C, Boyle PJ. Smoking compromises cause-specific survival in patients with operable colorectal cancer. Clin Oncol (R Coll Radiol). 2006; 18: 436-440.
  • 12
    Verla-Tebit E, Lilla C, Hoffmeister M, Brenner H, Chang-Claude J. Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study. Int J Cancer. 2006; 119: 630-635.
  • 13
    Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006; 106: 17-27.
  • 14
    Dresler CM. Is it more important to quit smoking than which chemotherapy is used? Lung Cancer. 2003; 39: 119-124.
  • 15
    Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993; 119: 383-390.
  • 16
    Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997; 89: 1782-1788.
  • 17
    Garces YI, Schroeder DR, Nirelli LM, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007; 30: 531-539.
  • 18
    Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010; 340: b5569.
  • 19
    National Cancer Institute. Screening of people at high-risk for lung cancer with low dose CT significantly reduces lung cancer death: twenty percent fewer cancer deaths seen among those screened with CT than with chest x-ray in a trial conducted by the American College of Radiology Imaging Network and the Lung Cancer Screening Study Group [press release]. Available at: http://www.cancer.gov/newscenter/pressreleases/NLSTresultsRelease Accessed November 17, 2010.
  • 20
    American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2010.
  • 21
    Dresler CM, Leon ME, Straif K, Baan R, Secretan B. Reversal of risk upon quitting smoking. Lancet. 2006; 368: 348-349.
  • 22
    Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small-cell lung cancer. Cancer Cause Control. 1991; 2: 105-112.
  • 23
    Sarna L. Smoking behaviors of women after diagnosis with lung cancer. J Nurse Scholarship. 1995; 27: 35-41.
  • 24
    Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; 110: 1199-1202.
  • 25
    Knudsen N, Schulman S, van den Hoek J, Fowler R. Insights on how to quit smoking: a survey of patients with lung cancer. Cancer Nurs. 1985; 8: 145-150.
  • 26
    Pinto BM, Trunzo JJ. Health behaviors during and after a cancer diagnosis. Cancer. 2005; 104: 2614-2623.
  • 27
    National Cancer Institute. Cancer Care Outcomes Research and Surveillance Consortium. Available at: http://healthservices.cacner.gov/cancors/ 2010. Accessed January 25, 2011.
  • 28
    Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004; 22: 2992-2996.
  • 29
    Malin JL, Ko C, Ayanian JZ, et al. Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer. 2006; 14: 837-848.
  • 30
    American Association for Public Opinion Research. Standard Definitions: Final dispositions of case codes and outcome rates for surveys. Available at: http://www.aapor.org/uploads/Standard_Definitions_04_08_Final.pdf. Accessed January 25, 2011.
  • 31
    Keating NL, Beth Landrum M, Arora NK, et al. Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol. 2010; 28: 4364-4370.
  • 32
    Catalano P. Representativeness of CanCORS participants relative to Surveillance, Epidemiology, and End Results (SEER) cancer registries. Paper presented at: 2008 Academy Health Annual Research Meeting; June 8-10, 2008; Washington, DC.
  • 33
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-376.
  • 34
    Cleeland CS RK. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994; 23: 129-138.
  • 35
    Turvey CL, Wallace RB, Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr. 1999; 11: 139-148.
  • 36
    Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs. 1995; 18: 385-392.
  • 37
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473-483.
  • 38
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705-714.
  • 39
    Ayanian JZ, Zaslavsky AM, Guadagnoli E, et al. Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol. 2005; 23: 576-6586.
  • 40
    Little RJ. Statistical Analysis With Missing Data. New York: John Wiley & Sons, Inc.; 1986.
  • 41
    He Y, Zaslavsky AM, Landrum MB, Harrington DP, Catalano P. Multiple imputation in a large-scale complex survey: a practical guide. Stat Methods Med Res. 2010; 19: 653-670.
  • 42
    Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, Inc.; 2000.
  • 43
    Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57: 1226-1228.
  • 44
    Simmons VN, Litvin EB, Patel RD, et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns. 2009; 77: 398-403.
  • 45
    Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009; 24( suppl 2): S480-S486.
  • 46
    Pentz RD, Berg CJ. Smoking and ethics: what are the duties of oncologists? Oncologist. 2010; 15: 987-993.
  • 47
    Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009; 66: 218-225.
  • 48
    American Society of Clinical Oncology. The Quality Oncology Practice Initiative: Program Overview. Available at: http://qopi.asco.org/Documents/QOPIProgramOverview9-21-09_000.pdf. Accessed January 26, 2010.
  • 49
    Cox LS, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 2002; 20: 3461-3469.
  • 50
    Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2003; 21: 355-365.
  • 51
    Garces YI, Schroeder DR, Nirelli LM, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer. 2004; 101: 116-124.
  • 52
    Klosky JL, Tyc VL, Hum A, et al. Establishing the predictive validity of intentions to smoke among preadolescents and adolescents surviving cancer. J Clin Oncol. 2010; 28: 431-436.
  • 53
    Fiore MC, Jaen C, Baker T, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.